Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]
News desk

Live news

Stock news, press releases, and legal notices, with ticker, type, source, and time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as each headline is ingested.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
F Stock news Wall Street Lowers the Bar: Why Ford's Q3 Earnings on Oct. 28 Could Trigger a Surprise October Breakout 24/7 Wall Street
APP Legal AppLovin Corporation (APP) Class Action Lawsuit: Investors Face November 16, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP GlobeNewswire
STLA Stock news Make or Break for Stellantis on Oct. 28: Can FaSTLAne 2030 Help Steer Carmarker From Its 52-Week Low? 24/7 Wall Street
SSTI Legal SSTI Stock Alert: Halper Sadeh LLC is Investigating Whether SoundThinking, Inc. is Obtaining a Fair Price for its Shareholders Business Wire
SNDK Stock news Sandisk's New Business Model Is Transforming the Business. Now Is the Time to Buy the Stock. The Motley Fool
BCS Stock news Barclays: AI-Driven Job Cuts And Overdone Bank Tax Fears Seeking Alpha
IBIT Stock news IBIT: I'm Waiting For $75,000 Bitcoin Seeking Alpha
AMGN Stock news Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer CNBC
ACXP Press release From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television ACCESS Newswire
AMGN Press release IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's... PR Newswire
PDO Stock news Cooking Up An Average Of 10% Yield From These Two CEFs Seeking Alpha
HRTH Legal HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders Business Wire
UNCY Legal Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between... PR Newswire
GPRO Legal GPRO Stock Alert: Halper Sadeh LLC is Investigating Whether GoPro, Inc. is Obtaining a Fair Price for its Shareholders Business Wire
LAW Legal ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO Newsfile Corp
CART Stock news Instacart Is Exploring a Sale, and Uber and DoorDash Are Circling 24/7 Wall Street
SPCX Stock news SpaceX Q3 Just Changed My AI Thesis (Upgrade) Seeking Alpha
BCPC Stock news Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold Seeking Alpha
MORN Stock news Vanguard Morningstar Growth ETF vs. Vanguard Information Technology ETF: Here's Which One I Believe Is the Clear Long-Term Winner. The Motley Fool
AXP Stock news AmEx Raised Its Profit Forecast and Announced Layoffs on the Same Day 24/7 Wall Street
Market Pulse

The same desk, in your inbox.

Market Pulse picks three headlines from the day, names the stock that moved, and shows the call that returns each one.

Monday, Wednesday, and Friday. Unsubscribe from any issue, or from account settings if you have one.

FAQ

Frequently asked questions

Is the live news desk the same feed as the API?
The desk shows the same articles in the browser: ticker, type, source, and published time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as soon as a row is ingested. A Free API key returns the last year. Pro keys search the full archive and also include the summary and the original URL.
Why is the live news desk delayed?
Signed-out visitors and Free accounts see this desk 15 minutes behind ingestion, across the last year of headlines. Pro, including the 7-day trial, sees the full archive as soon as headlines are ingested. A Free API key has the same 15-minute delay. The delay is the plan, not an outage, and the status page stays green while the delayed view is on.
How far back does the live news desk go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices, 15 minutes behind ingestion. Pro, including the 7-day trial, sees the full archive as new rows are ingested. Page size is 20. A Free API key returns the last year. Pro keys search the full archive.
How do I see stock news without the 15-minute delay?
Start the 7-day Pro trial and sign in. A card is required. Pro is $15 a month, or $162 a year, and this desk then shows the full archive as headlines are ingested. Signed-out visitors and Free accounts still see the last year of headlines 15 minutes behind. A Free API key stays at 100 requests a day, the same delay, and the last year. One trial per email.
What do the columns on the news desk mean?
Ticker is the symbol attached to the article. Type is stock news, press release, or legal. Headline is the title. Source is the publisher or wire. Published is the article time in Eastern Time. Page size is 20. Use the type buttons when you want wires only, or legal notices kept out of the list.
Can I search the live news desk by ticker?
Yes. The desk has a ticker search, a headline search, a source menu, and buttons for stock news, press releases, and legal notices. Those filters stay on this page. The same filters exist on GET /v1/news if you want the JSON, including the summary and the original URL. Page size on the desk is 20.
How often do new stock headlines appear?
Sources are polled every second, including nights and weekends. Pro, including the 7-day trial, sees a row as soon as it is ingested. Signed-out visitors and Free accounts see that same row 15 minutes later. The desk is a browser view of the API feed, not a second dataset.